Chemical Synthesis of Antibody–Hapten Conjugates Capable of Recruiting the Endogenous Antibody to Magnify the Fc Effector Immunity of Antibody for Cancer Immunotherapy
出版年份 2021 全文链接
标题
Chemical Synthesis of Antibody–Hapten Conjugates Capable of Recruiting the Endogenous Antibody to Magnify the Fc Effector Immunity of Antibody for Cancer Immunotherapy
作者
关键词
-
出版物
JOURNAL OF MEDICINAL CHEMISTRY
Volume 65, Issue 1, Pages 323-332
出版商
American Chemical Society (ACS)
发表日期
2021-12-28
DOI
10.1021/acs.jmedchem.1c01480
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Complement-Dependent Activity of CD20-Specific IgG Correlates With Bivalent Antigen Binding and C1q Binding Strength
- (2021) Sina Bondza et al. Frontiers in Immunology
- Site-Selective Chemoenzymatic Modification on the Core Fucose of an Antibody Enhances Its Fcγ Receptor Affinity and ADCC Activity
- (2021) Chao Li et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- FDA approves 100th monoclonal antibody product
- (2021) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Fc‐binding antibody‐recruiting molecules targeting prostate‐specific membrane antigen: defucosylation of antibody for efficacy improvement
- (2020) Koichi Sasaki et al. CHEMBIOCHEM
- Binding mechanisms of therapeutic antibodies to human CD20
- (2020) Anand Kumar et al. SCIENCE
- Margetuximab for the treatment of HER2-positive metastatic breast cancer
- (2020) Paolo Tarantino et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Detection and quantification of free sulfhydryls in monoclonal antibodies using maleimide labeling and mass spectrometry
- (2019) Anna C. Robotham et al. mAbs
- Glycoengineering of Antibodies for Modulating Functions
- (2019) Lai-Xi Wang et al. Annual Review of Biochemistry
- Considerations for the Design of Antibody-Based Therapeutics
- (2019) Dennis R. Goulet et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Antibody glycoengineering strategies in mammalian cells
- (2018) Qiong Wang et al. BIOTECHNOLOGY AND BIOENGINEERING
- The CD20-specific engineered toxin antibody MT-3724 exhibits lethal effects against mantle cell lymphoma
- (2018) Shengjian Huang et al. Blood Cancer Journal
- Engineering of Fc Fragments with Optimized Physicochemical Properties Implying Improvement of Clinical Potentials for Fc-Based Therapeutics
- (2018) Chunpeng Yang et al. Frontiers in Immunology
- Past, Present, and Future of Rituximab—The World’s First Oncology Monoclonal Antibody Therapy
- (2018) Timothy M. Pierpont et al. Frontiers in Oncology
- Cellular Cytotoxicity of Next-Generation CD20 Monoclonal Antibodies
- (2018) Karl R. VanDerMeid et al. Cancer Immunology Research
- Structure, heterogeneity and developability assessment of therapeutic antibodies
- (2018) Yingda Xu et al. mAbs
- Modulating IgG effector function by Fc glycan engineering
- (2017) Tiezheng Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Nanobody Activation Immunotherapeutic that Selectively Destroys HER2-Positive Breast Cancer Cells
- (2015) Melissa A. Gray et al. CHEMBIOCHEM
- Current ADC Linker Chemistry
- (2015) Nareshkumar Jain et al. PHARMACEUTICAL RESEARCH
- Rhamnose Glycoconjugates for the Recruitment of Endogenous Anti-Carbohydrate Antibodies to Tumor Cells
- (2014) Rachael T. C. Sheridan et al. CHEMBIOCHEM
- Antibody-Recruiting Molecules: An Emerging Paradigm for Engaging Immune Function in Treating Human Disease
- (2012) Patrick J. McEnaney et al. ACS Chemical Biology
- Tetraspanin CD37 Directly Mediates Transduction of Survival and Apoptotic Signals
- (2012) Rosa Lapalombella et al. CANCER CELL
- Chemoenzymatic Glycoengineering of Intact IgG Antibodies for Gain of Functions
- (2012) Wei Huang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Chemoenzymatic Synthesis and Fcγ Receptor Binding of Homogeneous Glycoforms of Antibody Fc Domain. Presence of a Bisecting Sugar Moiety Enhances the Affinity of Fc to FcγIIIa Receptor
- (2011) Guozhang Zou et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- l-Rhamnose Antigen: A Promising Alternative to α-Gal for Cancer Immunotherapies
- (2010) Wenlan Chen et al. ACS Chemical Biology
- Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity
- (2010) E. Mossner et al. BLOOD
- Engineered Fc variant antibodies with enhanced ability to recruit complement and mediate effector functions
- (2010) Gregory L. Moore et al. mAbs
- Optimization of Fc-mediated effector functions of monoclonal antibodies
- (2009) William R Strohl CURRENT OPINION IN BIOTECHNOLOGY
- Profiling Human Serum Antibodies with a Carbohydrate Antigen Microarray
- (2009) Oyindasola Oyelaran et al. JOURNAL OF PROTEOME RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now